Following a series of “most favored nation” (MFN) pricing deals with 17 large pharma companies, the Trump administration ...
Portfolio Receipts growth of 10% to $925 million; Royalty Receipts growth of 13%Net cash provided by operating activities of $718 millionRaised ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in ...
Investment Monitor on MSN
Angelini Pharma agrees $4.1bn Catalyst Pharmaceuticals acquisition
Under the definitive agreement, Italian pharmaceutical group will buy all outstanding shares of Catalyst Pharmaceuticals for ...
The move marks Italy’s Angelini Pharma’s entry into the U.S. market.
Purdue Pharma will pay the DOJ $225 million in a criminal settlement and members of the Sackler family who own the Oxycontin-maker also contribute billions of dollars to a bankruptcy deal, but the ...
The pharma index has surged 15 per cent between April 2 and May 11, 2026, outperforming key benchmark indices during the ...
The 340B Prescription Drug Anti-Discrimination Act protects one of the few tools we have that helps keep healthcare ...
6don MSNOpinion
Americans want big pharma reform. Candidates should deliver
Having spent 12 years on Capitol Hill, I know just how rare it is to find an issue with real bipartisan consensus. That’s why ...
Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities ...
The pharma royalty funding market hit a record $10 billion in 2025. A single AI experiment that improved a cancer drug in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results